Literature DB >> 13678566

Can Enterococcal Infections Initiate Sepsis Syndrome?

Peter Linden1.   

Abstract

Enterococci are the third most common nosocomial bloodstream pathogen and frequently are the causative pathogen(s) of intra-abdominal, genitourinary, surgical wound, endovascular, or other serious infections. In addition to a diverse spectrum of intrinsic and acquired antimicrobial resistance mechanisms, some strains of enterococci exhibit numerous virulence factors that facilitate mucosal adherence, tissue invasiveness, endovascular attachment, and inflammation production. However, the opportunistic nature of enterococcal infection coupled with animal models of experimental enterococcal and mixed infection have caused many to question the independent capacity of this organism to incite severe sepsis or septic shock. Despite evidence suggesting that this organism possesses low intrinsic virulence, observational and interventional trials of enterococcal bacteremia and sepsis strongly support the notion that Enterococcus is capable of promulgating sepsis as a solitary or copathogen with more serious sequelae in the immunocompromised hosts. Monomicrobial enterococcal bacteremia appears to be increasing during the glycopeptide-resistant era, which bolsters the notion that pure enterococcal sepsis is a real entity.

Entities:  

Year:  2003        PMID: 13678566     DOI: 10.1007/s11908-003-0016-8

Source DB:  PubMed          Journal:  Curr Infect Dis Rep        ISSN: 1523-3847            Impact factor:   3.725


  55 in total

Review 1.  Relationships between enterococcal virulence and antimicrobial resistance.

Authors:  L M Mundy; D F Sahm; M Gilmore
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

2.  Infection-derived Enterococcus faecalis strains are enriched in esp, a gene encoding a novel surface protein.

Authors:  V Shankar; A S Baghdayan; M M Huycke; G Lindahl; M S Gilmore
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

3.  Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial.

Authors:  B L Warren; A Eid; P Singer; S S Pillay; P Carl; I Novak; P Chalupa; A Atherstone; I Pénzes; A Kübler; S Knaub; H O Keinecke; H Heinrichs; F Schindel; M Juers; R C Bone; S M Opal
Journal:  JAMA       Date:  2001-10-17       Impact factor: 56.272

4.  Attributable mortality rate and duration of hospital stay associated with enterococcal bacteremia.

Authors:  F J Caballero-Granado; B Becerril; L Cuberos; M Bernabeu; J M Cisneros; J Pachón
Journal:  Clin Infect Dis       Date:  2001-02-07       Impact factor: 9.079

5.  Association between resistance to vancomycin and death in cases of Enterococcus faecium bacteremia.

Authors:  J M Garbutt; M Ventrapragada; B Littenberg; L M Mundy
Journal:  Clin Infect Dis       Date:  2000-03       Impact factor: 9.079

6.  Profound differences in leukocyte-endothelial cell responses to lipopolysaccharide versus lipoteichoic acid.

Authors:  Bryan G Yipp; Graciela Andonegui; Christopher J Howlett; Stephen M Robbins; Thomas Hartung; May Ho; Paul Kubes
Journal:  J Immunol       Date:  2002-05-01       Impact factor: 5.422

7.  The cell wall components peptidoglycan and lipoteichoic acid from Staphylococcus aureus act in synergy to cause shock and multiple organ failure.

Authors:  S J De Kimpe; M Kengatharan; C Thiemermann; J R Vane
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

8.  Microbial synergy in experimental intra-abdominal abscess.

Authors:  A B Onderdonk; J G Bartlett; T Louie; N Sullivan-Seigler; S L Gorbach
Journal:  Infect Immun       Date:  1976-01       Impact factor: 3.441

9.  Major trends in the microbial etiology of nosocomial infection.

Authors:  D R Schaberg; D H Culver; R P Gaynes
Journal:  Am J Med       Date:  1991-09-16       Impact factor: 4.965

10.  Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock.

Authors:  Djillali Annane; Véronique Sébille; Claire Charpentier; Pierre-Edouard Bollaert; Bruno François; Jean-Michel Korach; Gilles Capellier; Yves Cohen; Elie Azoulay; Gilles Troché; Philippe Chaumet-Riffaud; Philippe Chaumet-Riffaut; Eric Bellissant
Journal:  JAMA       Date:  2002-08-21       Impact factor: 56.272

View more
  5 in total

1.  Enterococcus faecalis infection activates phosphatidylinositol 3-kinase signaling to block apoptotic cell death in macrophages.

Authors:  Jun Zou; Nathan Shankar
Journal:  Infect Immun       Date:  2014-09-29       Impact factor: 3.441

2.  Enterococcal leucine-rich repeat-containing protein involved in virulence and host inflammatory response.

Authors:  Sophie Brinster; Brunella Posteraro; Hélène Bierne; Adriana Alberti; Samira Makhzami; Maurizio Sanguinetti; Pascale Serror
Journal:  Infect Immun       Date:  2007-07-09       Impact factor: 3.441

3.  Clostridium glycolicum bacteremia in a bone marrow transplant patient.

Authors:  Sameer Elsayed; Kunyan Zhang
Journal:  J Clin Microbiol       Date:  2007-03-07       Impact factor: 5.948

4.  Global prevalence of antibiotic resistance in blood-isolated Enterococcus faecalis and Enterococcus faecium: a systematic review and meta-analysis.

Authors:  Seyedeh Marzieh Jabbari Shiadeh; Ali Pormohammad; Ali Hashemi; Parnian Lak
Journal:  Infect Drug Resist       Date:  2019-09-02       Impact factor: 4.003

5.  Experimental infection of Enterococcus faecalis in red tilapia (Oreochromis hybrid) revealed low pathogenicity to cause streptococcosis.

Authors:  Rifky Rizkiantino; Fachriyan Hasmi Pasaribu; Retno Damajanti Soejoedono; Sucitya Purnama; Danny Bagus Wibowo; I Wayan Teguh Wibawan
Journal:  Open Vet J       Date:  2021-06-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.